Get started
Pfizer Inc (Extended Hours)Pfizer Inc (Extended Hours)Pfizer Inc (Extended Hours)

Pfizer Inc (Extended Hours)

No trades
See on Supercharts
Overview News
Ideas
Discussions Seasonals

PFE trade ideas

Symmetrical Triangle/Rising Wedge.Earnings 7-28 BMO Neutral pattern until a trendline is broken. Targets over the triangle are bullish targets if triangle breaks to the upside. Targets below the structure are bearish targets if this breaks to the downside. Price has broken bottom trendline of the triangle and recovered using a prior gap as support. Doji candle on Friday/indecision. Short percent is 1.23% approximate and ratio is 2.9. Earnings can make going long or short tricky so I will wait and see what happens. Longer term I feel this is a short due to the rising wedge. You may see this chart differently than I do. No recommendation. There is an old bearish rising wedge ( LOOK LEFT) in this chart just below $40. This pattern has not been validated. This pattern is not valid until the bottom trendline is broken. If history repeats itself, this rising wedge will eventually be broken.
NYSE:PFEShort
by lauralea
1
$PFE is finding support at its 50 day line. Can it move higher?Notes: * Strong up trend on all time frames * Great earnings track record * Building a base for the past ~7months * Consolidating around its 50 day line with decreasing volume on the daily, weekly and monthly time frames * This indicates that the buyers and sellers are agreeing on this price range * Currently bouncing off of its 50 day line with higher than average volume Technicals: Sector: Healthcare - Drug Manufacturers - General Relative Strength vs. Sector: 1.22 Relative Strength vs. SP500: 1.11 U/D Ratio: 1.65 Base Depth: 33.25% Distance from breakout buy point: -14.42% Volume 7.08% above its 15 day avg. Trade Idea: * This is offering a low risk entry * You can enter now as the price is just bouncing off of its 50 day line with higher than average volume * If you're looking for a better entry you can look for one around the 50.67 area as that should serve as support * This stock usually has local tops when the price closes around 14.24% above its 50 EMA * Consider selling into strength if the price closes 14.04% to 14.44% (or higher) above its 50 EMA * The last closing price is 0.98% away from its 50 EMA
NYSE:PFELong
by HaseebKhan_90
Here's an easy support & resistance strategyAccumulate in the lower part of the lines. You can use this to accumulate a dividend stock of an extremely fundamentally sound company. We can do this for a certain time after we notice a channel pattern form. I am not a financial advisor and this is not financial advice. This is for paper trading or simulated trading practices only. Trading is risky and you should consult with a financial advisor before taking on any risk. Any risk taken is your own doing and I will not be liable for your actions.
NYSE:PFELong
by WatsonsView
Pfizer: Playing the range againPfizer Short Term We look to Sell at 54.06 (stop at 56.08) Bespoke resistance is located at 54.50. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 54.60 level. We are trading at overbought extremes. Our profit targets will be 46.80 and 44.60 Resistance: 54.50 / 56.32 / 61.71 Support: 50.00 / 46.50 / 40.94 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NYSE:PFEShort
by Saxo
Pfizer Might Be Feeling SicklyBig pharma names like Pfizer have held up better than most parts of the market, but now the Dow member might be feeling sickly. The main pattern on today’s chart is the series of higher lows since March 2021 and lower highs since December. These converging trendlines have produced a triangle that PFE appears to have broken to the downside. Attention could now focus on the April low of $47.12 because a close below that level would represent a lower low. Next, PFE bounced at its 200-day simple moving average (SMA) in early March and early May. However, this month it ripped through the SMA without a pause. Has it lost relevance as support? Finally, the stock made a higher high and lower low on the weekly chart: a bearish outside candle. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. You Can Trade, Inc. is also a wholly owned subsidiary of TradeStation Group, Inc., operating under its own brand and trademarks. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
NYSE:PFE
by TradeStation
Pfizer in a Bullish patternPfizer seems to be in a bullish pattern as indicated by the bullish BAT pattern. Also this has been confirmed by green candles on Heiken with two days consecutive gains. In addition price has moved above the fib level of 38.2% and the trend line resistance which is an indication that we have a solid support at this point. Target at fib level of 61.8% which is 53.75. That accumulates around 7 percent profit. Stop loss according to the risk reward ratio.
NYSE:PFELong
by Muneeb567
2
Pfizer at resistancePfizer Short Term - We look to Sell at 54.62 (stop at 56.31) Bespoke resistance is located at 54.70. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 54.60 level. Trading has been mixed and volatile. Our profit targets will be 49.84 and 46.85 Resistance: 54.70 / 56.32 / 61.71 Support: 50.00 / 47.50 / 40.94 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NYSE:PFEShort
by Saxo
Pfizer:Pure Technical Play!Pfizer Short Term - We look to Sell at 53.30 (stop at 55.53) Price continues to trade within the triangle formation. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 53.56 level. Our profit targets will be 48.29 and 43.36 Resistance: 53.56 / 56.32 / 61.71 Support: 47.50 / 45.44 / 40.94 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’) . Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NYSE:PFEShort
by VantageMarkets